ThRombosis ExclUsion STudy

TerminatedOBSERVATIONAL
Enrollment

5,935

Participants

Timeline

Start Date

June 25, 2018

Primary Completion Date

March 29, 2023

Study Completion Date

September 5, 2024

Conditions
Deep Venous ThrombosesPulmonary EmbolismVenous Thromboembolism
Interventions
DIAGNOSTIC_TEST

DDimer test

Measuring the level of DDimer in blood sample

Trial Locations (20)

18015

St Luke's University Health Network, Bethlehem

18103

Lehigh Hospital, Allentown

19107

Jefferson University Hospital, Philadelphia

27710

Duke Hemostasis and Thrombosis Research Center, Durham

42718

Taylor regional Hospital, Campbellsville

43210

Ohio State University, Columbus

46202

Indiana University Health, Indianapolis

60611

Northwestern Medical Center, Chicago

63110

Washington University, St Louis

75390

UT Southwestern, Dallas

06510

Yale New Haven Hospital, New Haven

02114

Massachusetts General Hospital, Boston

Unknown

Cliniques Universitaires St Luc, Brussels

CHU, Angers

CHU, Dijon

CHU, Grenoble

CHU, Rouen

University Hospital S. Orsola-Mapighi, Bologna

Hospital Universitario Virgen del Rocio, Seville

General Hospital, Soria

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Diagnostica Stago

INDUSTRY

NCT03477968 - ThRombosis ExclUsion STudy | Biotech Hunter | Biotech Hunter